Patent · US Active

Inhibitors of glutaminyl cyclase

US8772508B2 · kind B2 · utility

0Cited by
5References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 18, 2008
Grant dateJul 8, 2014
Priority date
Expiry dateNov 29, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formula (I), combinations and uses thereof for disease therapy,or a pharmaceutically acceptable salt, solvate or polymorph thereof, including all tautomers, stereoisomers and polymorphs thereof, wherein A, B and R1 are as defined throughout the description and the claims.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.